Saturday - November 23, 2024
Kura Oncology Announces Global Strategic Collaboration With Kyowa Kirin
November 22, 2024
PALO ALTO, California, Nov. 22 -- Cooley, a law firm, issued the following news release:

San Diego - November 20, 2024 - Cooley advised clinical-stage biopharmaceutical company Kura Oncology (Nasdaq: KURA) on its global strategic collaboration with Kyowa Kirin to develop and commercialize ziftomenib, Kura's selective oral menin inhibitor that is being investigated for the treatment of acute myeloid leukemia (AML) and other hematologic malignancies.

Under the terms of th . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products